Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer.
about
Multifaceted role of prohibitin in cell survival and apoptosisCasein kinase 1 proteomics reveal prohibitin 2 function in molecular clockWDR5 Expression Is Prognostic of Breast Cancer Outcome.Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics.Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (BIG3) is predicted to interact with its partner through an ARM-type α-helical structureA-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells.Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions.BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells.Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancerRecent insights into the actions of IGFBP-6.Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration.Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.The prohibitin protein complex promotes mitochondrial stabilization and cell survival in hematologic malignanciesBIG3 inhibits insulin granule biogenesis and insulin secretion.Prohibitin 2 localizes in nucleolus to regulate ribosomal RNA transcription and facilitate cell proliferation in RD cells.COMP-prohibitin 2 interaction maintains mitochondrial homeostasis and controls smooth muscle cell identity.Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells
P2860
Q28087391-F333C72B-C221-4394-8F2E-C06E5230744CQ28481281-D758CBCD-7D96-4BF8-9DA1-D65731AF61FFQ30402762-FE522A4B-0F28-4321-A000-353B4DC4BE99Q33687329-7A59806E-A0E0-435C-9CCD-4664D316E736Q33896624-7E4CA729-373A-4EFD-A3CF-72F38412E291Q33908447-3EC8C75B-9617-49DE-A5E4-3DF1F4CD7217Q34648456-9FC58C5E-1613-4B8E-A2C0-A87AB4A722AFQ35656014-DC42B304-546A-47D2-9558-E813D474C801Q35674177-4454E64D-5FEF-4C81-AAF1-F817B77F5161Q35690623-507CD468-D23A-44C7-AF9C-09AE8AE5836DQ37217695-9202E171-6F32-4CB1-9F13-DCF57CA3B70CQ37226250-8340CE93-90D5-444D-94BB-CD56F73A3617Q38789308-80FFC1F8-C977-48CE-9FBE-95E74F0869B3Q42371544-C5532DAA-C239-4437-81FA-E97003613BE8Q42706280-F616E8BC-24BF-41A0-9B0C-44AAD3E5B90EQ49450301-BEA7C662-AE99-477C-A544-C83611139BA8Q55358435-A3CEC633-8F72-4EB7-9938-F254BAAF5195Q58757254-DBE85628-1237-40E4-8080-C035772A8957
P2860
Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Activation of an estrogen/estr ...... of PHB2/REA in breast cancer.
@en
Activation of an estrogen/estr ...... of PHB2/REA in breast cancer.
@nl
type
label
Activation of an estrogen/estr ...... of PHB2/REA in breast cancer.
@en
Activation of an estrogen/estr ...... of PHB2/REA in breast cancer.
@nl
prefLabel
Activation of an estrogen/estr ...... of PHB2/REA in breast cancer.
@en
Activation of an estrogen/estr ...... of PHB2/REA in breast cancer.
@nl
P2093
P1433
P1476
Activation of an estrogen/estr ...... of PHB2/REA in breast cancer.
@en
P2093
Arata Shimo
Jae-Hyun Park
Jung-Won Kim
Meng-Lay Lin
Miki Akiyama
Tatsuhiko Tsunoda
Tomomi Ueki
Toshihiko Nishidate
Toyomasa Katagiri
Yataro Daigo
P304
P356
10.1111/J.1349-7006.2009.01209.X
P577
2009-05-06T00:00:00Z